4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001415889-25-019000
Chief Financial Officer sold 20,000 shares at $10.05 ($200,972)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Piscitelli Dominic Chief Financial Officer | 2025-07-01 | Sale 10b5-1 | −20,000 | $10.05 | $200,972 | 48,317 | D |
| Open-market sales · 20,000 sh · avg $10.05 · $200,972 | |||||||
Loading xslF345X05/form4-07022025_080708.xml…